1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址（主办单位微信公众号信息）：

https://www.academax.com/PME/home

https://www.sciencedirect.com/journal/precision-medicine-and-engineering

4、投稿系统：

https://www2.cloud.editorialmanager.com/preme/default2.aspx

5、联系邮箱：Pmejournal@zju.edu.cn

（主办单位微信公众号信息）

6、出刊日期：季刊，一年出版四期。

7、主办单位微信公众号信息：免文章处理费。

8、官方微信公众号：PME-精准医学与工程

主办单位微信公众号：浙大学术期刊

2026年6月12日星期五

Precision Medicine and Engineering《精准医学与工程》简介

【主办单位微信公众号信息】

浙大学术期刊2026年5月15日

《精准医学与工程（英文）》于2024年创刊，由浙江大学附属第二医院王伟林教授担任主编，浙江大学高分子科学与工程学院毛峥伟教授、浙江大学附属第二医院丁元教授担任执行主编。期刊主要关注精准医学领域内生物材料、生物技术和纳米技术的临床发现、医学进展和技术创新，特色是基础医学、纳米医学、精准诊疗、生物医学工程和生物信息学等领域的跨学科融合。

01  研究目的与研究范围

·  精准医学：蛋白质与基因组学研究、生物信息与大数据技术开发

·  精准诊断：分子医学诊断技术、新型成像技术、新型分子探针

·  精准递送：新型纳米药物递送体系、药物控释与药物载体材料研究

·  精准治疗：靶向治疗、免疫治疗、基因治疗、细胞疗法

02  主编团队

03  期刊特色

01Interdisciplinary Research：

关注于基础医学、纳米医学、精准诊疗、生物医学工程和生物信息学等领域的跨学科融合。

02Open Access：

研究成果将向全球观众免费开放，显著提高其可见性和影响力。

03Waived Publication Charges：

免文章处理费。

04Rapid Review and Publlication：

35天内完成从送审到首次同行评审。

04  期刊更多信息和联系方式

联系我们：

Email: Pmejournal@zju.edu.cn.

期刊主页：

https://www.academax.com/PME/home

Guide for authors

【官网信息】

About the journal

Aims and scope

The

aim of Precision Medicine and Engineering is to provide a forum for the

communication of researchers focusing on clinical discoveries, medical

advancements, and technological advances in biomaterials, biotechnology,

and nanotechnology in precision medicine. The scope of Precision

Medicine and Engineering will cover the following key subject areas:

Discovery of biomarkers, mechanism of oncogenesis, and tumor development.

Advances in diagnostic techniques for cancers especially for early diagnosis.

Novel targets and targeted therapy strategies developments.

In vivo image techniques including diagnostics and image-guided therapy.

Tumor immunotherapy including checkpoint inhibitors, vaccines, immunoregulation, etc.

Biomaterials advance in personalized therapy including drug delivery system development, and novel therapeutic strategies.

Precision Medicine and Engineering is an open access, peer-reviewed journal sponsored by Zhejiang University.

Peer review

This

journal follows a single anonymized review process. Your submission

will initially be assessed by our editors to determine suitability for

publication in this journal. If your submission is deemed suitable, it

will typically be sent to a minimum of two reviewers for an independent

expert assessment of the scientific quality. The decision as to whether

your article is accepted or rejected will be made by our editors.

Read more about peer review.

Our editors are not involved in making decisions about papers which:

they have written themselves.

have been written by family members or colleagues.

relate to products or services in which they have an interest.

Any

such submissions will be subject to the journal's usual procedures and

peer review will be handled independently of the editor involved and

their research group. Read more about editor duties.

Authors

may submit a formal appeal request to the editorial decision, provided

it meets all the requirements and follows the procedure outlined in

Elsevier’s Appeal Policy. Only one appeal per submission will be

considered and the appeal decision will be final.

Special issues and article collections

The

peer review process for special issues and article collections follows

the same process as outlined above for regular submissions, except, a

guest editor may send the submissions out to the reviewers and may

recommend a decision to the journal editor. The journal editor oversees

the peer review process of all special issues and article collections to

ensure the high standards of publishing ethics and responsiveness are

respected and is responsible for the final decision regarding acceptance

or rejection of articles.

Open access

We refer you to our open access information page to learn about open access options for this journal.

Ethics and policies

Ethics in publishing

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

Submission declaration

When authors submit an article to an Elsevier journal it is implied that:

the

work described has not been published previously except in the form of a

preprint, an abstract, a published lecture, academic thesis or

registered report. See our policy on multiple, redundant or concurrent

publication.

the article is not under consideration for publication elsewhere.

the

article's publication is approved by all authors and tacitly or

explicitly by the responsible authorities where the work was carried

out.

if

accepted, the article will not be published elsewhere in the same form,

in English or in any other language, including electronically, without

the written consent of the copyright-holder.

To verify compliance with our journal publishing policies, we may check your manuscript with our screening tools.

Authorship

All authors should have made substantial contributions to all of the following:

The conception and design of the study, or acquisition of data, or analysis and interpretation of data

Drafting the article or revising it critically for important intellectual content.

Final approval of the version to be submitted.

All

authors are accountable for all aspects of the work, to ensure that

questions related to the accuracy or integrity of any part of the work

are appropriately investigated and resolved.

Authors

should appoint a single corresponding author to communicate with the

journal during the editorial process. This individual submits the

manuscript and all required documentation to the journal, and serves as

the primary contact between the journal and the co-authors. Only the

corresponding author’s affiliation will be used to determine eligibility

for a publishing agreement, and possible discounts related to it.

Affiliations of other co-authors are not relevant for eligibility.

Changes to authorship

The

editors of this journal generally will not consider changes to

authorship once a manuscript has been submitted. It is important that

authors carefully consider the authorship list and order of authors and

provide a definitive author list at submission.

The policy of this journal around authorship changes:

All

authors must be listed in the manuscript and their details entered into

the submission system. Changes can only be made prior to acceptance,

and only if approved by the journal editor. This includes additions,

deletion, or rearrangement of author names.

Requests

to change authorship must be made by the corresponding author using the

Authorship Change Request form. The corresponding author must provide

the reason for the request to the journal editor with written

confirmation from all authors, including any authors being added or

removed, that they agree with the changes. Requests which do not comply

with the instructions outlined in the form will not be considered.

This

journal does not allow authorship changes after acceptance. This

includes additions, deletions, or the rearrangement of author names,

including changes to the corresponding author.

The review process may be paused while a change in authorship request is being considered.

Change

requests made by the authors without the Authorship Change Request form

or editor approval may result in the rejection of the manuscript, or

retraction if the article has already been published.

Declaration of competing interests

All

authors must disclose any financial and personal relationships with

other people or organizations that could inappropriately influence or

bias their work. Examples of potential competing interests include:

Employment

Consultancies

Stock ownership

Honoraria

Paid expert testimony

Patent applications or registrations

Grants or any other funding

Affiliation with the journal as an Editor or Advisory Board Member

The declarations tool should always be completed.

Authors with a journal affiliation to declare should enter the following text under “Other Activities” within the  declarations tool and should inform the journal and publisher prior to completing the submission process:

Given

their role as [AUTHOR JOURNAL ROLE TITLE], [AUTHOR NAME] had no

involvement in the peer-review of this article and has no access to

information regarding its peer-review. Full responsibility for the

editorial process for this article was delegated to another journal

editor.

Editorial

disclosure statements will be included as a footnote and/or in the

declaration of competing interest section of the article.

Authors with no competing interests to declare should select the option "I have nothing to declare".

The

resulting Word document containing your declaration should be uploaded

at the "attach/upload files" step in the submission process. It is

important that the Word document is saved in the .doc/.docx file format.

Author signatures are not required.

Funding sources

Authors

must disclose any funding sources who provided financial support for

the conduct of the research and/or preparation of the article. The role

of sponsors, if any, should be declared in relation to the study design,

collection, analysis and interpretation of data, writing of the report

and decision to submit the article for publication. If funding sources

had no such involvement this should be stated in your submission.

List funding sources in this standard way to facilitate compliance to funder's requirements:

Funding:

This work was supported by the National Institutes of Health [grant

numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle,

WA [grant number zzzz]; and the United States Institutes of Peace [grant

number aaaa].

It

is not necessary to include detailed descriptions on the program or

type of grants, scholarships and awards. When funding is from a block

grant or other resources available to a university, college, or other

research institution, submit the name of the institute or organization

that provided the funding.

If no funding has been provided for the research, it is recommended to include the following sentence:

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Declaration of generative AI use

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.

Generative

AI and AI-assisted technologies (“AI tools”) have been rapidly adopted

in research and scholarly publishing, offering significant benefits

while requiring clear standards for responsible and transparent use.

Authors

preparing a manuscript for this journal may use AI tools to support

them. However, these tools must never be used as a substitute for human

critical thinking, expertise and evaluation. AI tools may only be

applied with human oversight and control.

Please

read Elsevier’s detailed author policy on the use of AI tools, as

stated in Elsevier’s generative AI policies for journals.

Ultimately, authors are responsible and accountable for the contents of their work. This includes accountability for:

Carefully

reviewing and verifying the accuracy, comprehensiveness, and

impartiality of all AI-generated output (including checking the sources,

as AI-generated references can be incorrect or fabricated).

Editing

and adapting all material thoroughly to ensure the manuscript

represents the author’s authentic and original contribution and reflects

their own analysis, interpretation, insights and ideas.

Ensuring accuracy and originality of any AI generated images and provide appropriate attribution where relevant.

Ensuring

the use of any tools or sources, AI-based or otherwise, is made clear

and transparent to readers. If AI tools have been used, we require a

disclosure statement upon submission; please see example below.

Ensuring

the manuscript is developed in a way that safeguards data privacy,

intellectual property and other rights, by checking the terms and

conditions of any AI tool that is used.

Finally,

authors must not list or cite AI tools as an author or co-author on the

manuscript since authorship implies responsibilities and tasks that can

only be attributed to, and performed by, humans.

The

use of AI tools in the manuscript preparation process must be declared

by adding a statement at the end of the manuscript when the paper is

first submitted. The statement will appear in the published work and

should be placed in a new section before the references list. An

example:

Title of new section: Declaration of generative AI and AI-assisted technologies in the manuscript preparation process.

Statement:

During the preparation of this work the author(s) used [NAME OF TOOL /

SERVICE] in order to [REASON]. After using this tool/service, the

author(s) reviewed and edited the content as needed and take(s) full

responsibility for the content of the published article.

The

declaration does not apply to the use of basic tools, such as tools

used to check grammar, spelling and references. In addition, authors are

not required to disclose the use of AI tools or features within

specialist disability-related assistive technology, provided these are

used solely for accessibility purposes.

If you have nothing to disclose, you do not need to add a statement.

Please

note: to protect authors’ rights and the confidentiality of their

research, this journal does not currently allow academic editors and

reviewers to upload an unpublished manuscript into a generative AI tool,

as is stated in Elsevier’s generative AI policies for journals.

However, AI tools may be used in a supportive capacity by editors and

reviewers to improve structure and language of the review report or

editorial decision letter or to conduct a background literature search.

Elsevier is actively evaluating compliant AI tools and may revise this

policy in the future.

Preprints

Preprint sharing

Authors

may share preprints in line with Elsevier's article sharing policy.

Sharing preprints, such as on a preprint server, will not count as prior

publication.

We advise you to read our policy on multiple, redundant or concurrent publication.

Use of inclusive language

Inclusive

language acknowledges diversity, conveys respect to all people, is

sensitive to differences, and promotes equal opportunities. Authors

should ensure their work uses inclusive language throughout and contains

nothing which might imply one individual is superior to another on the

grounds of:

age

gender

race

ethnicity

culture

sexual orientation

disability or health condition

We

recommend avoiding the use of descriptors about personal attributes

unless they are relevant and valid. Write for gender neutrality with the

use of plural nouns ("clinicians, patients/clients") as default.

Wherever possible, avoid using "he, she," or "he/she."

No

assumptions should be made about the beliefs of readers and writing

should be free from bias, stereotypes, slang, reference to dominant

culture and/or cultural assumptions.

These

guidelines are meant as a point of reference to help you identify

appropriate language but are by no means exhaustive or definitive.

......

更多详见：

https://www.sciencedirect.com/journal/precision-medicine-and-engineering/publish/guide-for-authors